|
Delayed
Japan Exchange
21:22:43 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 1,307.00 JPY | -1.73% |
|
+0.85% | -7.42% |
| 03-25 | Renascience Inc. cancelled the transaction announced on November 28, 2025 | CI |
| 03-05 | Renascience Inc. announced that it has received ¥459.972744 million in funding from CVI Investments, Inc. | CI |
| Market Cap | 18.32B 115M 98.71M 92.34M 84.43M 159M 11.03B 161M 1.09B 425M 5.54B 432M 423M | P/E 2025 |
118x | P/E 2026 | -71.8x |
|---|---|---|---|---|---|
| Enterprise Value | 14.92B 93.8M 80.38M 75.2M 68.75M 130M 8.98B 131M 890M 346M 4.51B 352M 345M | EV / Sales 2025 |
87.3x | EV / Sales 2026 | 290x |
| Free-Float |
43.01% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -1.43% | ||
| 1 week | +0.85% | ||
| Current month | -11.72% | ||
| 1 month | -15.15% | ||
| 3 months | -15.15% | ||
| 6 months | -27.89% | ||
| Current year | -7.42% |
| 1 week | 1,270 |  | 1,398 |
| 1 month | 1,101 | | 1,577 |
| Current year | 1,101 | | 2,185 |
| 1 year | 1,101 | | 2,342 |
| 3 years | 263 | | 3,310 |
| 5 years | 263 | | 3,310 |
| 10 years | 263 | | 3,310 |
| Manager | Title | Age | Since |
|---|---|---|---|
Toshio Miyata
PSD | President | 65 | 2025-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Toshio Miyata
CHM | Chairman | 65 | 2020-03-31 |
Hiroaki Nojo
BRD | Director/Board Member | 67 | 2024-05-31 |
Akihiko Ito
BRD | Director/Board Member | 66 | 2025-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.73% | +0.85% | -39.86% | +145.05% | 113M | |
| -0.67% | +5.39% | +75.21% | +127.54% | 1,119B | |
| +1.04% | +4.07% | +52.29% | +65.39% | 651B | |
| -0.17% | +5.67% | +25.60% | +80.40% | 468B | |
| -1.38% | +4.02% | +41.64% | +42.38% | 374B | |
| -0.52% | +2.72% | +24.32% | +41.06% | 302B | |
| -1.06% | +4.76% | +1.19% | +12.65% | 259B | |
| +1.03% | +5.83% | +51.11% | +72.96% | 238B | |
| -0.53% | +2.34% | -17.77% | -53.66% | 208B | |
| +0.42% | +5.63% | +27.86% | +92.24% | 181B | |
| Average | -0.33% | +5.17% | +24.16% | +62.60% | 380B | |
| Weighted average by Cap. | -0.23% | +4.95% | +43.93% | +73.00% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 132M 830K 711K 665K 608K 1.15M 79.45M 1.16M 7.87M 3.06M 39.9M 3.12M 3.05M | 68M 427K 366K 343K 313K 591K 40.93M 598K 4.06M 1.58M 20.55M 1.6M 1.57M |
| Net income | 113M 710K 609K 569K 521K 983K 68.02M 993K 6.74M 2.62M 34.15M 2.67M 2.61M | -301M -1.89M -1.62M -1.52M -1.39M -2.62M -181M -2.64M -17.95M -6.98M -90.97M -7.1M -6.95M |
| Net Debt | -1.8B -11.31M -9.69M -9.07M -8.29M -15.64M -1.08B -15.81M -107M -41.72M -544M -42.46M -41.54M | -3.4B -21.39M -18.33M -17.15M -15.67M -29.58M -2.05B -29.89M -203M -78.89M -1.03B -80.29M -78.56M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | JP¥1,307.00 | -1.73% | 87,000 |
| 26-08-24 | JP¥1,330.00 | +2.15% | 445,200 |
| 26-08-21 | JP¥1,302.00 | -4.82% | 420,600 |
| 26-08-20 | JP¥1,368.00 | +3.25% | 528,900 |
| 26-08-19 | JP¥1,325.00 | +1.92% | 346,300 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4889 Stock
Select your edition
All financial news and data tailored to specific country editions
